Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Archives of Pathology & Laboratory Medicine
A R PatelJ R Shah
American Journal of Hematology
Y MatznerC Hershko
Cancer Detection and Prevention
E Aulbert, C G Schmidt
Biomedicine / [publiée Pour L'A.A.I.C.I.G.]
A Iu BaryshnikovA Glazunov
Terapevticheskiĭ arkhiv
E R PolosukhinaA Iu Baryshnikov